| 西罗莫司对高脂饮食诱导的NAFLD大鼠外周血Treg/Th17细胞的影响 |
| |
| 引用本文： | 荣爱梅,张超,吴慧丽. 西罗莫司对高脂饮食诱导的NAFLD大鼠外周血Treg/Th17细胞的影响[J]. 实用肝脏病杂志, 2021, 24(1): 10-13. DOI: 10.3969/j.issn.1672-5069.2021.01.004 |
| |
| 作者姓名： | 荣爱梅 张超 吴慧丽 |
| |
| 作者单位： | 450000 郑州市 郑州大学附属郑州中心医院消化内科 |
| |
| 基金项目： | 河南省自然科学基金资助项目(编号:182300410293)。 |
| |
| 摘 要： | 目的 研究西罗莫司对高脂饮食诱导的非酒精性脂肪性肝病(NAFLD)大鼠外周血Treg/Th17细胞的影响。方法 随机将60只SD大鼠分为西罗莫司干预组、模型组和对照组,每组20只。采用高脂饮食喂养12周建立NAFLD模型,在造模成功后,在其中20只动物,给予西罗莫司干预2周。采用ELISA法检测血清白介素-10(IL-10)、IL-17和肿瘤坏死因子-α(TNF-α)水平,使用全自动生化分析仪检测血生化指标,使用FACSVia型流式细胞仪检测外周血Treg和Th17细胞百分比。结果 干预后,西罗莫司干预组血清AST和ALT水平分别为(134.9±15.3)U/L和(109.4±18.2)U/L,显著低于模型组【(151.1±28.9)U/L和(128.9±17.7)U/L,P<0.05】;血清TG、TC和LDL-C水平分别为(0.9±0.3)mmol/L、(2.6±0.8)mmol/L和(3.3±1.2)mmol/L,显著低于模型组【(1.1±0.5)mmol/L、(3.6±1.3)mmol/L和(5.4±1.8)mmol/L,P＜0.05】,而血清HDL-C水平为(1.3±0.5)mmol/L,显著高于模型组【(0.7±0.4) mmol/L,P＜0.05】;血清IL-10水平为(68.9±26.6)pg/ml,显著高于模型组【(37.8±17.2)pg/ml,P＜0.05],而血清IL-17和TNF-α水平分别为(13.2±3.3)pg/ml和(0.7±0.2)ng/ml,显著低于模型组【(22.6±4.0)pg/ml和(1.2±0.4)ng/ml,P＜0.05】;西罗莫司干预组外周血Treg细胞百分比为(4.5±0.7)%,Th17细胞百分比为(1.7±0.6)%,Treg/Th17比值为(2.6±0.7),与模型组比,差异显著【(3.8±0.9)%、(2.8±1.1)%和(1.5±0.7),P＜0.05]。结论 应用西罗莫司干预高脂饮食诱导的NAFLD大鼠能减轻炎症反应,纠正外周血Treg/Th17细胞比值失衡状态,可能有助于阻止NAFLD进展,值得进一步研究。
|
| 关 键 词： | 非酒精性脂肪性肝病 高脂饮食 西罗莫司 Treg/Th17细胞比值 大鼠 |
Effect of sirolimus on peripheral blood Treg/Th17 cell ratio in high fat diet-induced NAFLD in rats |
| |
| Rong Aimei,Zhang Chao,Wu Huili. Effect of sirolimus on peripheral blood Treg/Th17 cell ratio in high fat diet-induced NAFLD in rats[J]. Journal of Clinical Hepatology, 2021, 24(1): 10-13. DOI: 10.3969/j.issn.1672-5069.2021.01.004 |
| |
| Authors: | Rong Aimei Zhang Chao Wu Huili |
| |
| Affiliation: | Department of Gastroenterology,Central Hospital Affiliated to Zhengzhou University, Zhengzhou450000,Henan Province, China |
| |
| Abstract: | Objective The aim of this study was to investigate the effect of sirolimus on peripheral blood Treg/Th17 cell ratio in high fat diet-inducednon-alcoholic fatty liver disease(NAFLD)in rats.Methods 60 SD rats were randomly divided into sirolimus intervention group,model group and control group with 20 rats in each group.The NAFLD model was established by high fat diet feeding for 12 weeks and when the model was successfully built up,20 rats were fed with sirolimus for two weeks.Serum aspartate aminotransferase(AST),alanine aminotransferase(ALT),blood triglyceride(TG),total cholesterol(TC),high density lipoprotein cholesterol(HDL-C),low density lipoprotein cholesterol(LDL-C),serum interleukin-10(IL-10),IL-17,tumor necrosis factor-α(TNF-α)and peripheral blood regulatory T lymphocyte(Treg)/T help cell 17(Th17)were detected.Results At the end of the experiment,serum AST and ALT levels insirolimus-intervened group were(134.9±15.3)U/L and(109.4±18.2)U/L,both significantly lower than【(151.1±28.9)U/L and(128.9±17.7)U/L,respectively,P<0.05】in model group;blool TG,TC and LDL-C levels were(0.9±0.3)mmol/L,(2.6±0.8)mmol/L and(3.3±1.2)mmol/L,significantly lower than【(1.1±0.5)mmol/L,(3.6±1.3)mmol/L and(5.4±1.8)mmol/L,respectively,P<0.05】in the model,while blood HDL-C level was(1.3±0.5)mmol/L,much higher than【(0.7±0.4)mmol/L,P<0.05】in the model;serum IL-10 level was(68.9±26.6)pg/ml,much higher than【(37.8±17.2)pg/ml,P<0.05】,while serum IL-17 and TNF-αlevels were(13.2±3.3)pg/ml and(0.7±0.2)ng/ml,significantly lower than【(22.6±4.0)pg/ml and(1.2±0.4)ng/ml,P<0.05】in the model;the percentage of Treg cells was(4.5±0.7)%,the percentage of Th17 cells was(1.7±0.6)%and the ratio of Treg/Th17 cells was(2.6±0.7),significantly different compared to【(3.8±0.9)%,(2.8±1.1)%and(1.5±0.7),respectively,P<0.05】in the model.Conclusion The administration of sirolimus could inhibit inflammatory response and correct Treg/Th17 cell imbalance in rats with high fat diet-induced NAFLD,which mightalleviates hepatic steatosis. |
| |
| Keywords: | Non-alcoholic fatty liver disease Sirolimus High fat diet Treg/Th17 cells Rats |
| 本文献已被 CNKI 维普 等数据库收录！ |
| 点击此处可从《实用肝脏病杂志》浏览原始摘要信息 |
|
点击此处可从《实用肝脏病杂志》下载免费的PDF全文 |
|
